Search Results - "Kailayangiri, S"

PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation by Albring, J C, Inselmann, S, Sauer, T, Schliemann, C, Altvater, B, Kailayangiri, S, Rössig, C, Hartmann, W, Knorrenschild, J R, Sohlbach, K, Groth, C, Lohoff, M, Neubauer, A, Berdel, W E, Burchert, A, Stelljes, M

Get full text

Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia by Rossig, C, Pule, M, Altvater, B, Saiagh, S, Wright, G, Ghorashian, S, Clifton-Hadley, L, Champion, K, Sattar, Z, Popova, B, Hackshaw, A, Smith, P, Roberts, T, Biagi, E, Dreno, B, Rousseau, R, Kailayangiri, S, Ahlmann, M, Hough, R, Kremens, B, Sauer, M G, Veys, P, Goulden, N, Cummins, M, Amrolia, P J

“…Trials with second generation CD19 chimeric antigen receptors (CAR) T-cells report unprecedented responses but are associated with risk of cytokine release…”
Get full text

The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting by Kailayangiri, S, Altvater, B, Meltzer, J, Pscherer, S, Luecke, A, Dierkes, C, Titze, U, Leuchte, K, Landmeier, S, Hotfilder, M, Dirksen, U, Hardes, J, Gosheger, G, Juergens, H, Rossig, C

“…Novel treatment strategies are needed to cure disseminated Ewing sarcoma. Primitive neuroectodermal features and a mesenchymal stem cell origin are both…”
Get full text

Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging by Liebsch, L, Kailayangiri, S, Beck, L, Altvater, B, Koch, R, Dierkes, C, Hotfilder, M, Nagelmann, N, Faber, C, Kooijman, H, Ring, J, Vieth, V, Rossig, C

“…Background: Novel treatment strategies in Ewing sarcoma include targeted cellular therapies. Preclinical in vivo models are needed that reflect their activity…”
Get full text

SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma by Isfort, Ilka, Cyra, Magdalene, Elges, Sandra, Kailayangiri, Sareetha, Altvater, Bianca, Rossig, Claudia, Steinestel, Konrad, Grünewald, Inga, Huss, Sebastian, Eßeling, Eva, Mikesch, Jan-Henrik, Hafner, Susanne, Simmet, Thomas, Wozniak, Agnieszka, Schöffski, Patrick, Larsson, Olle, Wardelmann, Eva, Trautmann, Marcel, Hartmann, Wolfgang

“…Synovial sarcoma is a soft tissue malignancy characterized by a reciprocal t(X;18) translocation. The chimeric SS18-SSX fusion protein acts as a…”
Get full text

SS18-SSX drives CREB activation in synovial sarcoma by Cyra, Magdalene, Schulte, Miriam, Berthold, Ruth, Heinst, Lorena, Jansen, Esther-Pia, Grünewald, Inga, Elges, Sandra, Larsson, Olle, Schliemann, Christoph, Steinestel, Konrad, Hafner, Susanne, Simmet, Thomas, Wardelmann, Eva, Kailayangiri, Sareetha, Rossig, Claudia, Isfort, Ilka, Trautmann, Marcel, Hartmann, Wolfgang

“…Purpose Synovial sarcoma (SySa) is a rare soft tissue tumor characterized by a reciprocal t(X;18) translocation. The chimeric SS18-SSX fusion protein…”
Get full text

The ganglioside antigen G sub(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting by Kailayangiri, S, Altvater, B, Meltzer, J, Pscherer, S, Luecke, A, Dierkes, C, Titze, U, Leuchte, K, Landmeier, S, Hotfilder, M, Dirksen, U, Hardes, J, Gosheger, G, Juergens, H, Rossig, C

“…Background: Novel treatment strategies are needed to cure disseminated Ewing sarcoma. Primitive neuroectodermal features and a mesenchymal stem cell origin are…”
Get full text

The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting by Kailayangiri, S, Altvater, B, Meltzer, J, Pscherer, S, Luecke, A, Dierkes, C, Titze, U, Leuchte, K, Landmeier, S, Hotfilder, M, Dirksen, U, Hardes, J, Gosheger, G, Juergens, H, Rossig, C

“…Background: Novel treatment strategies are needed to cure disseminated Ewing sarcoma. Primitive neuroectodermal features and a mesenchymal stem cell origin are…”
Get full text